These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1. Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein M in lipid metabolism and cardiometabolic diseases. Borup A; Christensen PM; Nielsen LB; Christoffersen C Curr Opin Lipidol; 2015 Feb; 26(1):48-55. PubMed ID: 25551802 [TBL] [Abstract][Full Text] [Related]
4. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium. Ruiz M; Okada H; Dahlbäck B Lipids Health Dis; 2017 Feb; 16(1):36. PubMed ID: 28179022 [TBL] [Abstract][Full Text] [Related]
5. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation. Blaho VA; Galvani S; Engelbrecht E; Liu C; Swendeman SL; Kono M; Proia RL; Steinman L; Han MH; Hla T Nature; 2015 Jul; 523(7560):342-6. PubMed ID: 26053123 [TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons. Frej C; Linder A; Happonen KE; Taylor FB; Lupu F; Dahlbäck B J Cell Mol Med; 2016 Jun; 20(6):1170-81. PubMed ID: 26990127 [TBL] [Abstract][Full Text] [Related]
7. A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex. Frej C; Mendez AJ; Ruiz M; Castillo M; Hughes TA; Dahlbäck B; Goldberg RB Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1194-1205. PubMed ID: 28385702 [TBL] [Abstract][Full Text] [Related]
8. Involvement of CETP (Cholesteryl Ester Transfer Protein) in the Shift of Sphingosine-1-Phosphate Among Lipoproteins and in the Modulation of its Functions. Kurano M; Hara M; Ikeda H; Tsukamoto K; Yatomi Y Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):506-514. PubMed ID: 28126827 [TBL] [Abstract][Full Text] [Related]
9. Sphingosine 1-Phosphate and Atherosclerosis. Kurano M; Yatomi Y J Atheroscler Thromb; 2018 Jan; 25(1):16-26. PubMed ID: 28724841 [TBL] [Abstract][Full Text] [Related]
10. [Measurement of sphingosine 1-phosphate as a biomarker of atherosclerosis]. Kimura T; Okajima F; Murakami M Rinsho Byori; 2007 Apr; 55(4):358-62. PubMed ID: 17511266 [TBL] [Abstract][Full Text] [Related]
11. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M. Kurano M; Tsukamoto K; Ohkawa R; Hara M; Iino J; Kageyama Y; Ikeda H; Yatomi Y Atherosclerosis; 2013 Jul; 229(1):102-9. PubMed ID: 23664237 [TBL] [Abstract][Full Text] [Related]
12. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. Karuna R; Park R; Othman A; Holleboom AG; Motazacker MM; Sutter I; Kuivenhoven JA; Rohrer L; Matile H; Hornemann T; Stoffel M; Rentsch KM; von Eckardstein A Atherosclerosis; 2011 Dec; 219(2):855-63. PubMed ID: 21944699 [TBL] [Abstract][Full Text] [Related]
13. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Christoffersen C; Obinata H; Kumaraswamy SB; Galvani S; Ahnström J; Sevvana M; Egerer-Sieber C; Muller YA; Hla T; Nielsen LB; Dahlbäck B Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9613-8. PubMed ID: 21606363 [TBL] [Abstract][Full Text] [Related]
14. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein. Liu M; Seo J; Allegood J; Bi X; Zhu X; Boudyguina E; Gebre AK; Avni D; Shah D; Sorci-Thomas MG; Thomas MJ; Shelness GS; Spiegel S; Parks JS J Biol Chem; 2014 Jan; 289(5):2801-14. PubMed ID: 24318881 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes. Christensen PM; Bosteen MH; Hajny S; Nielsen LB; Christoffersen C Sci Rep; 2017 Nov; 7(1):14983. PubMed ID: 29118354 [TBL] [Abstract][Full Text] [Related]
16. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Galvani S; Sanson M; Blaho VA; Swendeman SL; Obinata H; Conger H; Dahlbäck B; Kono M; Proia RL; Smith JD; Hla T Sci Signal; 2015 Aug; 8(389):ra79. PubMed ID: 26268607 [TBL] [Abstract][Full Text] [Related]
17. Effects of apolipoprotein M in uremic atherosclerosis. Bosteen MH; Madsen Svarrer EM; Bisgaard LS; Martinussen T; Madsen M; Nielsen LB; Christoffersen C; Pedersen TX Atherosclerosis; 2017 Oct; 265():93-101. PubMed ID: 28866363 [TBL] [Abstract][Full Text] [Related]
18. Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate. Mishima Y; Kurano M; Kobayashi T; Nishikawa M; Ohkawa R; Tozuka M; Yatomi Y Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30279204 [TBL] [Abstract][Full Text] [Related]
20. Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation. Frej C; Andersson A; Larsson B; Guo LJ; Norström E; Happonen KE; Dahlbäck B Anal Bioanal Chem; 2015 Nov; 407(28):8533-42. PubMed ID: 26377937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]